GlassScriptPhysician profile
Michael R Duch
NPI 1962408856
$2,136.76
in general payments reported to CMS, 2019-2025
21 companies · $304 in 2025
The $304 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $157 · 2020: $15.41 · 2021: $250 · 2022: $480 · 2023: $400 · 2024: $530 · 2025: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $979 · Education: $255.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $978.69 |
| Education | $255.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $403.54 | 2021-2024 | Comprehensive, Comprehensive Shoulder System |
| Ferring Pharmaceuticals INC. | $302.78 | 2019-2025 | Euflexxa |
| Stryker Corporation | $302.39 | 2021-2025 | Triathlon, Blueprint Patient Specific Instrumentation |
| Depuy Synthes Sales INC. | $287.13 | 2019-2023 | Velys |
| Smith+Nephew, INC. | $171.64 | 2021-2023 | Q-Fix, Spatial Frame, Healicoil |
| Exact Sciences Corporation | $101.46 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Dynasplint Systems INC. | $99.96 | 2019-2025 | Dynasplint |
| Nuvasive, INC. | $74.41 | 2022 | |
| Bioventus LLC | $70.74 | 2022 | |
| Djo, LLC | $68.04 | 2025 | Aircast, Donjoy |
| Medtronic, INC. | $59.04 | 2024 | Intellis Adaptivestim |
| Avanos Medical | $36.13 | 2023 | Trivisc Sodium Hyaluronate |
| Astrazeneca Pharmaceuticals LP | $27.28 | 2024-2025 | Farxiga |
| Biocomposites INC | $20.25 | 2024 | |
| Phadia US INC. | $19.24 | 2025 | Immunocap |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $18.14 | 2021 | |
| Lilly USA, LLC | $15.88 | 2025 | Mounjaro, Zepbound |
| Ethicon US, LLC | $15.41 | 2020 | |
| Seapearl East, INC | $15.26 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $14.57 | 2023 | Exparel, Zilretta, Iovera |
| Horizon Therapeutics Plc | $13.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Duch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.